Theriva Biologics Inc (NASDAQ:TOVX) shares are trading lower by 15% to $0.17 Monday morning after the company announced a 1-for-25 reverse stock split. This reverse stock split will become effective ... Theriva Biologics (TOVX) is making noise in the field of immuno-oncology, supported by a promising pipeline.

Understanding the Context

The stock is up 79% in the past few days on the news the company’s lead clinical-stage ... Theriva Biologics, Inc. (AMEX:TOVX) stock is trading higher after the company announced it was selected as a finalist for Merck’s KGaA’s EMEA Advance Biotech Grant. What To Know: Finalists for the ...

Key Insights

Theriva Biologics, Inc. (NYSE: TOVX) stock rose on Monday, with a session volume of 114.18 million compared to the average volume of 15.61 million, as per data from Benzinga Pro. The company received ... Theriva Biologics Inc. Annual stock financials by MarketWatch.

Final Thoughts

View the latest TOVX financial statements, income statements and financial ratios. Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades. We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too. Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Catch the fastest live cricket scores and ball-by-ball commentary.

Get real-time updates, full scorecards, and match analysis for the IPL 2026 & all global and domestic series. Fintel on MSN: Theriva Biologics (TOVX) price target decreased by 37.50% to 2.55 The average one-year price target for Theriva Biologics (NYSEAM:TOVX) has been revised to $2.55 / share. This is a decrease of 37.50% from the prior estimate of $4.08 dated . The price ...